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Introduction
Trauma, cancer, aging and genetic diseases can result 
in bone lesions and bone defects. An important step 
in the repair of such defects is to provide suitable 
scaffolds to retain mechanical and functional 
integrity for bone regeneration. Hydroxyapatite 
(HA) is the most studied biomaterial used as a bone 
graft substitute, with its clinical application dating 
back to the 1970s.1-3
3RURXV +$ KDV QRZ UHSODFHG WKH GHQVH IRUP GXH
to its better integration into bone. After HA is 
implanted into bone defects, new bone grows into 
the pores.4, 5 However, HA has a low biodegradation 
rate.2, 3, 6 Another widely-studied inorganic material is 
calcium carbonate, which is low cost, safe, accessible, 
biocompatible, bioresorptive and osteoconductive.7, 8 
Calcium carbonate has three crystalline polymorphs, 
namely calcite, aragonite and vaterite.9, 10 The 
differences in the morphological forms of calcium 
carbonate may be related to their synthetic 
conditions. Calcite is the stable form and exists as 
a trigonal crystalline form in nature. Vaterite is the 
least stable and exists as a hexagonal crystalline form. 
In contact with water, vaterite slowly dissolves and 
recrystallises to a stable form.11
Aragonite occurs as the orthorhombic form and 
has been the exclusive focus of research attention 
due to its biocompatible properties.12 Aragonite 
is biocompatible and can be integrated into and 
replaced by bone.13, 14 However, due to its fast 
biodegradation rate, aragonite alone is not suitable 
as a bone graft. 
Our previous study demonstrated that a partially-
converted coralline HA/calcium carbonate can 
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be completely biodegraded with great osteogenic capacity.15 
6LQFH FRUDO LV DQ HQGDQJHUHG VSHFLHV DQG D OLPLWHG UHVRXUFH D
composite bone graft created by addition of aragonite into porous 
HA may enhance the biodegradation of HA whilst retaining 
ideal osteogenic capacity. However, it is a technical challenge to 
fabricate porous HA/aragonite using conventional methods. 
There are a variety of techniques for fabricating porous bone 
scaffolds. Traditional technologies include chemical foaming16 
and foam-gel technology,17, 18 solvent casting and particle leaching 
technology,19 IUHH]HGU\LQJ20 as well as thermally-induced phase 
separation.21 3RUH PDJQLWXGH VKDSH DQG LQWHUFRQQHFWLYLW\
however, are not completely controllable using these techniques. 
)XUWKHUPRUH DQ LGHDO ERQH JUDIW VKRXOG EH ELRFRPSDWLEOH DQG
biodegradable. It should also have suitable mechanical properties. 
The interconnected porous structure of bone grafts allows 
YDVFXODUL]DWLRQFHOOVSUHDGLQJDQGHIIHFWLYHWUDQVSRUWRIQXWULHQWV
oxygen, and waste, as well as growth factors. This process favours 
continuous ingrowth of bone tissue from the surface into the 
inner part of the scaffold.22 However, scaffolds with porosity 
designed for particular defects are hard to fabricate using most of 
these techniques.23-26
$GGLWLYH PDQXIDFWXULQJ DOVR WHUPHG WKUHHGLPHQVLRQDO '
printing, can be one solution to the design and fabrication of such 
bone scaffolds.27-29 Various additive manufacturing processing 
techniques allow the building of complex form scaffolds directly 
from a computer-aided design model in stereolithography 
file format.30 At present, a variety of additive manufacturing 
techniques involving stereolithography, fused deposition 
modelling, and selective laser sintering have been developed for 
tissue engineering applications.22, 29, 31 However, the products 
fabricated using these techniques may suffer from the effects of 
the high temperatures involved, which prevent the incorporation 
of bioactive molecules.28
7KHXVH RI ORZ WHPSHUDWXUH 'SULQWLQJ RI FDOFLXPSKRVSKDWH
cements has been demonstrated in the literature.32, 33 The binders 
used for calcium phosphate powders are acidic, which pose issues 
for biocompatibility.27, 28 In recent work, collagen or hydrogel 
KDV EHHQ XVHG WR GHYHORS 'SULQWHG VFDIIROGV HLWKHU DORQH RU
combined with other materials.34, 35 However, crosslinking is 
required to improve the mechanical strength and accuracy of 
'SULQWHGVFDIIROGV35, 36 In recent years, a new form of HA called 
HA cement has been developed for treating cranial defects.32 
)DVWVHWWLQJ FDOFLXP SKRVSKDWH FHPHQWV VXFK DV WHWUDFDOFLXP
SKRVSKDWH77&3DQGGLFDOFLXPSKRVSKDWHDQK\GURXV'&3$
use a sodium phosphate solution as the liquid phase and the 
setting time is around 5 minutes.32, 37
Natural bone forms at body temperature (37°C) and is a composite 
consisting of HA, calcium carbonate and other minerals deposited 
onto an organic extracellular matrix. The crystalline structure 
and composition differ from those of artificial calcium phosphate 
FHUDPLFVVXFKDV+$ƺWULFDOFLXPSKRVSKDWHƺ7&3DQGWKHLU
K\EULGVFDIIROGV+$7&3ZKLFKWDNHORQJHUWKDQQDWXUDOERQH 
to degrade after implantation.6 We hypothesise that to fabricate 
HA under near-physiological conditions (37°C) in combination 
with calcium carbonate may not only improve the mechanical 
strength of the scaffolds without crosslinking, but will also 
enhance the osteogenic and biodegradation properties. 
In this study, we report a novel HA/aragonite bone graft 
VXEVWLWXWHIDEULFDWHGE\ORZWHPSHUDWXUH'ELRSULQWLQJRQD'
bio-plotter®. The effect of printing parameters on the porosity 
and compression strength was analysed. The cytotoxicity and 
osteogenic capacity of the HA/aragonite was assessed in vitro 
XVLQJKXPDQXPELOLFDOFRUGPDWUL[PHVHQFK\PDOVWHPFHOOV6RIW
tissue responses to HA/aragonite were evaluated in vivo after 
implantation between the tibia and the tibialis anterior muscle in 




77&3 6KDQJKDL 5HERQH %LRPDWHULDOV &R /WG 6KDQJKDL
&KLQD '&3$ 6KDQJKDL 5HERQH %LRPDWHULDOV &R /WG DQG
DUDJRQLWH SRZGHUV 6LJPD$OGULFK 6W /RXLV02 86$ ZHUH
ground together for 20 minutes using a pestle and mortar. The 
PRODUUDWLRRI77&3'&3$ZDVDFFRUGLQJWRWKHHTXDWLRQ
                                                                                                             (1)
 
In brief, after being ground, 10 g of the combined powders were 
mixed with 5 g carrier liquid consisting of a gelatine solution in 
ZDWHU7KHSDVWHZDV ORDGHGLQWRD'%LRSORWWHU® (QYLVLRQWHF
GmbH, Gladbeck, Germany) through cartridges and printed 
within 30 minutes.
Design and optimization of parameters for bioplotting  
In this study computer-aided design software (Visual Machines, 
(QYLVLRQWHF *PE+ ZDV XVHG WR GHVLJQ WKH JULGOLNH VWUXFWXUH
RI+$DUDJRQLWHZKLFKZDV IRUPHG LQWR PP  PP  
mm blocks (Figure 17KHSDVWHZDVSULQWHGE\D'%LRSORWWHU® 
(QYLVLRQ'HYHORSHU(QYLVLRQWHF*PE+XVLQJDPPQR]]OH
with layer height of 0.4 mm.
To optimise the bioplotting process, a multi-level experimental 
trial was performed to analyse the effect of printing pressure, 
printing speed and distance between printed strands, and in total 
nine tests were performed. To compare the differently-printed 
' ELRSULQWHG ERQH JUDIW VDPSOHV WKH UHVXOWLQJ PHFKDQLFDO
properties, specifically the compressive strength and the porosity, 
were assessed. 
Characterization of HA/aragonite
X-ray powder diffraction of HA/aragonite and CaCO3 was 
SHUIRUPHG XVLQJ DQ ;ѡSHUW SRZGHU ;UD\ GLIIUDFWRPHWHU
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Chemical changes to the micro-structure were scrutinised by 
analysing the absorbances and positions of the infrared bands. 
The surface morphology of HA/aragonite was observed by 
VFDQQLQJHOHFWURQPLFURVFRS\ 6LULRQDQG4XDQWD)(,
)(,&RPSDQ\+LOOVERUR2586$IROORZLQJSODWLQXPVSXWWHU
coating for 300 seconds to avoid charging.
A universal material testing machine (Wuhan Guoliang Instrument 
Co. Ltd., Wuhan, China) was used to carry out the compression 




                                                                                                                (2)
Where m1 is the dry weight of the HA/aragonite, m2 is the weight 
of the HA/aragonite soaked in water, v is the volume of the HA/
DUDJRQLWHDQGǉLVWKHGHQVLW\RIZDWHU
Thermal analysis of the HA/aragonite was performed using a 
WKHUPRJUDYLPHWULF DQDO\VHU 3\ULV  3HUNLQ(OPHU :DOWKDP
0$86$LQWKHUDQJHRIѝq&DWDKHDWLQJUDWHRI.PLQ
   
In vitro assessments
The design of the in vitro tests is shown in Figure 2.
Cytotoxicity 
Test samples of HA/aragonite and gelatine sponge were diced into 
PPPPPPVL]HFXEHVDQGVRDNHGLQ'XOEHFFRѡVPRGLILHG
(DJOH PHGLXP) '0(0) PHGLXP /LIH 7HFKQRORJ\
7KHUPR)LVKHU6FLHQWLILF:DOWKDP0$86$RYHUQLJKW
Human umbilical cord matrix mesenchymal stem cells were 
isolated from umbilical cord of healthy pregnancies during 
normal deliveries at the end of gestation with informed consent 
6RXWK :DOHV 5(& 1R :$ 8PELOLFDO FRUGV ZHUH
ZDVKHGZLWK'0(0)GLFHGLQWRPP2, explanted into T25 
FXOWXUHIODVNVFRQWDLQLQJP/IHWDOERYLQHVHUXP)%6IRU
hours then transferred to complete culture medium which was 
'0(0) VXSSOHPHQWHG ZLWK  )%6 DQG  SHQLFLOOLQ
VWUHSWRP\FLQ /LIH 7HFKQRORJ\ 7KHUPR )LVKHU 6FLHQWLILF LQ D
5% CO2 atmosphere at 37°C. After 2 weeks, adherent cells were 
trypsinised for subpassage. Cells at passage three were seeded 
RQWRHDFKRIWKHWHVWVDPSOHVDW4 cells/well in a 96-well plate, 
while negative control cultures containing the same number of 
cells alone were cultured as a monolayer in wells of a 96-well plate 
without scaffolds. At 1, 3 and 7 days, the medium was replaced 
ZLWK  Ǆ/PHGLXP FRQWDLQLQJ  Ǆ/ GLPHWK\OWKLD]RO
\OGLSKHQ\OWHWUD]ROLXP EURPLGH 077 6LJPD$OGULFK
After incubating for 4 hours, the supernatant was carefully 
UHPRYHGDQGǄ/GLPHWK\OVXOIR[LGHZDVDGGHGWRHDFKZHOO
WRGLVVROYHWKHIRUPD]DQFU\VWDOV7KHSODWHVZHUHZUDSSHGLQIRLO
and incubated for 1 hour at room temperature. The supernatant 
was then transferred to a new 96-well plate, and the absorbance 
of each well was measured using a microplate reader at 570 nm 
wavelength (series No. 415-1387, BMG Labtech, Ortenberg, 
Germany).
Alkaline phosphatase assay 
$ONDOLQH SKRVSKDWDVH $/3 DFWLYLW\ RI KXPDQ XPELOLFDO FRUG
matrix mesenchymal stem cells on HA/aragonite and control 
VDPSOHVZDVTXDQWLILHGDFFRUGLQJWRWKHPDQXIDFWXUHUѡVSURWRFRO
DE$EFDP&DPEULGJH8.,QEULHIFHOOVDW4/well 
were seeded onto HA/aragonite, gelatine sponge or into blank 
ZHOOVDQGFXOWXUHGIRUGD\VLQ'0(0)VXSSOHPHQWHGZLWK
)%6DQGSHQLFLOOLQVWUHSWRP\FLQ7KH'0(0)ZDV
then replaced by osteogenic medium containing dexamethasone 
Ǆ0ƺJO\FHURSKRVSKDWH0DVFRUELFDFLGP0
)%6DQGSHQLFLOOLQVWUHSWRP\FLQ
)RU $/3 DVVD\ +$DUDJRQLWH VDPSOHV ZLWK DWWDFKHG FHOOV ZHUH















 Yan, C., Xia, Z.; et al.
www.biomat-trans.com
washed twice in cold phosphate-buffered saline, then cells were lysed 
LQ$/3DVVD\EXIIHURQLFHIRUKRXUVZLWKVKDNLQJWKHQSURFHVVHG
DFFRUGLQJWRWKHPDQXIDFWXUHUѡVSURWRFRO$/3ZDV quantified using 
DPLFURSODWHUHDGHU)/82VWDU2PHJD%0*/DE7HFKDWDQRSWLFDO
GHQVLW\RIQP$/3DFWLYLW\ǄPROPLQPLQRU8P/ZDVWKHQ
calculated from the following equation
                                                                                                               (3)
Where B is the amount of p-nitrophenol in the sample well, 
calculated from the standard curve; ƝT is the reaction time; V is 
the original sample volume added to each sample well and D is the 
sample dilution factor.
Degradation test
The degradation test was carried out following a standard testing 
PHWKRG ,62 39 The HA/aragonite was ground into 
SDUWLFOHVDQG WKHSDUWLFOH VL]HZDVFRQWUROOHG WR–ǄPE\
sieving. The particles were soaked in Tris-HCl buffer (pH 7.4) for 
3, 7 or 14 days with a mixing speed of 120 r/min at 37°C. After 3, 
RUGD\VWKHSDUWLFOHVZHUHILOWHUHGǄPDQGZDVKHGWZLFH
with deionised water. The filtered particles were then dried in an 
oven for 24 hours to constant weight.
In vivo implantation 
6L[ 6SUDJXH'DZOH\ PDOH UDWV ZLWK D ZHLJKW LQ WKH UDQJH RI
200– J ERXJKW IURP /DERUDWRU\ $QLPDO &HQWHU +XD]KRQJ
8QLYHUVLW\ RI 6FLHQFH DQG 7HFKQRORJ\ OLFHQFH 1R 6&;.
0057) were employed in this study. The HA/aragonite scaffolds 
and control gelatine sponges were implanted juxtapositionally 
between the tibia and the anterior tibialis muscle (Figure 2) of six 
adult rats (three per group) to observe any soft/hard tissue reaction 
to the HA/aragonite in comparison with gelatine sponge controls. 
7KHSURFHGXUHZDVDSSURYHGE\WKH$QLPDO(WKLFDO&RPPLWWHH
DW7RQJML0HGLFDO 6FKRRO+XD]KRQJ8QLYHUVLW\RI 6FLHQFH DQG
Technology on October 1, 2017 (IACUC No.738). 
6L[ZHHNVDIWHURSHUDWLRQWKHUDWVZHUHHXWKDQLVHGDQGWKHLPSODQWHG
tissues were harvested and fixed immediately in 4% glutaraldehyde/0.1 




All samples were dehydrated and embedded into LR White resin 
/RQGRQ5HVLQ&RPSDQ\5HDGLQJ8.DWq&IRUDPLQLPXP
of 48 hours. Undecalcified 10 µm sections were obtained using 
a Leica RM2155 motorised microtome and stained with 1% 
WROXLGLQHEOXHLQP07ULVEXIIHUS+6WDLQHGVHFWLRQVZHUH
examined using an Olympus BX51 research light microscope 
(Olympus, Tokyo, Japan) and digital photomicrographs were 
captured using a Zeiss Axiocam and Axiovision software (Carl 
Zeiss Vision GmbH, Hallbergmoos, Germany).
The areas of interest identified by light microscopy were selected, 
post fixed in 1% osmium tetroxide and re-embedded in LR White 
resin, then 100 nm ultrathin sections were obtained using a glass 
NQLIH RQ DQ 8OWUDFXW ( XOWUDPLFURWRPH /HLFD 0LFURV\VWHPV
/WG :HW]ODU *HUPDQ\ VWDLQHG ZLWK XUDQ\O DFHWDWH DQG OHDG





$OO GDWD DUH SUHVHQWHG DV PHDQ r VWDQGDUG HUURU 6( DQG
statistical analysis was performed by analysis of variance using 
*UDSK3DG3ULVP*UDSK3DG6RIWZDUH,QF/D-ROOD&$86$
The differences between the two groups at each time point were 
DQDO\VHGE\WZRZD\DQDO\VLVRIYDULDQFHZLWKWKHFULWHULRQƹ 
Results
Optimization of 3D bio printing processing parameters 
The effects of bioprinting parameters of pressure, printing speed 
Figure 2. ([SHULPHQWDOGHVLJQRIin vitro and in vivo tests. The blocks of HA/aragonite were sterilised by autoclaving at 
q&SVLSVL 3DIRUPLQXWHV)XUWKHUin vitro and in vivo tests were designed to compare between HA/
DUDJRQLWHDQGFOLQLFDOO\DSSOLHGJHODWLQHVSRQJH+$K\GUR[\DSDWLWH8	3EXUDQ\ODFHWDWHDQGOHDGFLWUDWHVWDLQLQJ
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and distance between strands on the compression strength and 
porosity of the end product are shown in Table 1. The results 
of analysis of the data are shown in Table 2, and the original 
calculation and data leading to the results in Table 2 can be 
referred to in the Additional Table 1. 
Table 2 shows the range analysis of variance tests. Mean k1, k2 
and k3 are the mean values of the sum of compression strength at 
WKHVDPHOHYHO)RUWKHVDPHIDFWRUUDQJH5LVWKHDYHUDJHYDOXH
difference between the maximum value and the minimum value 
of k at different levels.
In Table 2, k1, k2 and k3 are the mean values of the sum of 
compression strength at the same level, which can be calculated 
IURP(TXDWLRQ
(4)
:KHUH 6 LV WKH DYHUDJH FRPSUHVVLRQ VWUHQJWK RI SUHVVXUH
IDFWRU $ 6 LV WKH DYHUDJH FRPSUHVVLRQ VWUHQJWK RI SULQWLQJ
VSHHG IDFWRU% DQG 6 LV WKH DYHUDJH FRPSUHVVLRQ VWUHQJWKRI
GLVWDQFHEHWZHHQ VWUDQGV IDFWRU&)RU WKH VDPH IDFWRU UDQJH
R is the average value difference between the maximum value 
DQG WKHPLQLPXPYDOXHRI. DW WKHGLIIHUHQW OHYHOV$FFRUGLQJ
to the range analysis of compression strength, without any 
interaction between the three factors, the results of RA > RB > 
RC shown in Table 2 indicate that the printing pressure has the 
greatest effect on compression strength, printing speed takes 
second place, and distance between strands has the least effect. 
)RUSULQWLQJSUHVVXUHIDFWRU$NA1 > kA2 > kA3, which indicates 
that as the printing pressure increases, the compression strength 
GHFUHDVHV)RUSULQWLQJVSHHGIDFWRU%NB1 > kB2 > kB3, indicating 
that as the printing speed increases, the compression strength 
GHFUHDVHV )RU GLVWDQFH EHWZHHQ VWUDQGV IDFWRU & NC1 > kC2 > 
kC3, which means that as distance between strands increases, the 
compression strength decreases. According to these results, the 
best combination of the three factors should be A1B1C1, namely 
DSULQWLQJSUHVVXUHRI03DSULQWLQJVSHHGRIPPVDQG
distance between strands of 1 mm.
According to the results of the range analysis for porosity, without 
any interaction between the three factors, the result of R1 > R2 
> R3, shown in Table 2, indicates that the printing pressure has 
the greatest effect, followed by printing speed in second place, 
ZKLOHGLVWDQFHEHWZHHQVWUDQGVKDVWKHOHDVWHIIHFW)RUSULQWLQJ
pressure (factor A), kA3 > kA1 > kA2, which means that as printing 
pressure increases, porosity decreases but porosity is the lowest 
ZKHQ SULQWLQJ SUHVVXUH UHDFKHV DQ LQWHUPHGLDWH YDOXH )RU
printing speed (factor B), kB1 > kB3 > kB2 which indicates that as 
the printing speed increases, the porosity decreases, but porosity 
is the lowest when printing speed reaches an intermediate value. 
)RUGLVWDQFHEHWZHHQVWUDQGVIDFWRU&NC1 > kC3 > kC2, indicating 
that when distance between strands increases, porosity decreases, 
but porosity is the lowest when distance between strands reaches 
an intermediate value. According to these results, the best 
combination of the three factors should be A1B3C3, namely 
DSULQWLQJSUHVVXUHRI03DSULQWLQJVSHHGRIPPVDQG
distance between strands of 1.2 mm.
In general, the compression strength decreases as porosity 
increases. At a fixed printing pressure, the higher the printing 
speed the higher the porosity, which implies a lower compression 
Table 1. The effect of bioplotting parameters on hydroxyapatite/aragonite end products





(B) Printing speed 
(mm/s)
(C) Distance between strands 
(mm)
1 0.6 25 1 2.49 ± 0.14 37.0 ± 1.4
2 0.6 27 1.1 2.43 ± 0.23 37.5 ± 1.5
3 0.6 30 1.2 1.11 ± 0.07 42.8 ± 1.8
4 0.7 25 1.1 1.13 ± 0.11 41.1 ± 1.1
5 0.7 27 1.2 1.34 ± 0.09 30.2 ± 1.5
6 0.7 30 1 1.58 ± 0.13 40.7 ± 1.3
7 0.8 25 1.2 1.03 ± 0.08 41.8 ± 1.1
8 0.8 27 1 0.56 ± 0.05 40.2 ± 1.2
9 0.8 30 1.1 0.75 ± 0.07 35.5 ± 1.6
1RWH'DWDDUHH[SUHVVHGDVWKHPHDQr6(
Table 2. Range analysis of compression strength and porosity of hydroxyapatite/aragonite
Factors Pressure (MPa) Printing speed (mm/s) Distance between strands (mm)
Compression strength
k1 2.01 1.55 1.54
k2 1.35 1.44 1.44
k3 0.78 1.15 1.16
R 1.23 0.4 0.38
3RURVLW\
k1 39.1 40.0 39.3
k2 27.3 36.0 38.0
k3 39.2 39.7 38.3
R 11.9 3.0 1.0
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strength. It can therefore be seen that the porosity exerts a lesser 
effect on compression strength compared with the printing 
SUHVVXUH IURP )ROORZLQJ WKH DERYH WHVWV IRU WKH in vivo and 
in vitro characterisation, samples were fabricated adopting 
processing parameters from test sample 1 in view of the resultant 
higher compressive strength.
Material characterization of HA/aragonite
The surface structure, cross-section and X-ray spectroscopy 
analysis of HA/aragonite, visualised by scanning electron 
microscopy, are shown in Figure 37KHSRUH VL]HZDV DURXQG
ǄPZLWKVRPHYLVLEOHPLFURSRUHVRQWKHVXUIDFHDQGZLWKLQ
the scaffolds.
The results of X-ray diffraction analysis of HA/aragonite and 
calcium carbonate are shown in Figure 4. In Figure 4, the 
UHIOHFWLRQSHDNVYLVLEOHDWDǀYDOXHRI4 in the calcium carbonate 
spectrum indicate that the calcium carbonate in the HA/aragonite 
belongs to aragonite.12, 13 In the X-ray diffraction patterns of the 
HA/aragonite, the diffraction peaks of calcium carbonate in the 
HA/aragonite are still visible. More importantly, the diffraction 
SHDNVRI+$DSSHDUDWǀYDOXHVRIqqqqDQGq
which correspond to (002), (211), (300), (130) and (213) planes, 
respectively. These diffraction peaks are in good agreement with 
WKHGLIIUDFWLRQVWDQGDUGGDWDRISXUH+$-&3'63')40
7KH )7,5 VSHFWUD RI +$DUDJRQLWH DQG FDOFLXP FDUERQDWH DUH
shown in Figure 57KH)7,5VSHFWUDRI WKHUHIHUHQFHVDPSOHV
show absorptions at v1—963 cm–1, v3—1036 and 1095 cm–1, v4—
568 and 600 cm–1ZKLFKDUHGXHWR324
3– ions, while OH groups 
are visible at 630 cm–1.15, 41, 427KH)7,5VSHFWUDRIWKHUHIHUHQFH
VDPSOHVVKRZDEVRUSWLRQVDWDǅSHDNRIFP–1DǅSHDN
of 853.8 cm–1DǅSHDNRIFP–1DQGǅSHDNVRIDQG
712.2 cm–1 corresponding to CO3
2– 7KH ǅ DEVRUSWLRQ SHDN RI
CO3
2– is a single peak for calcite calcium carbonate, but a double 
peak for aragonite calcium carbonate.40
The results of thermogravimetric analysis of HA/aragonite 
are shown in Figure 6. The thermal decomposition process 
consists of three stages. In the first stage, as the temperature 
increases from 0°C to 200°C, gelatine in the HA/aragonite begins 
Figure 4. X-ray diffraction analysis of hydroxyapatite/aragonite and calcium carbonate (CaCO3 7KH  LQ ǀ
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to decompose, resulting in weight loss. The decomposition 
products, CO2 and H2O, are emitted as gases. As the temperature 
continues to increase to 600°C, the trend of weight loss decreases 
until the weight reaches around 92%. At the second stage, as the 
temperature increases from 600°C to 800°C, CaCO3 in the HA/
aragonite begins to dramatically decompose, resulting in massive 
weight loss. The decomposition product, CO2, is emitted as a gas. 
In the third stage, when the temperature increases to 1000°C, 
there is little weight loss and the residual weight tends to be stable 
because the residual components are CaO and HA with higher 
melting temperatures, which are stable at 1000°C, so no further 
weight loss will occur even as the temperature increases.43 The 
weight percentage of CaCO3 can be calculated from the following 
equation
(5)
Thus, the weight percentage of CaCO3 is around 35%.
MTT and ALP assays
MTT assay demonstrated that there were no significant differences 
in cell viability between cells grown on HA/aragonite and cells 
alone at days 7 or 14 (Figure 7), indicating that HA/aragonite 
is nontoxic to human umbilical cord matrix mesenchymal cells. 
However, the result of MTT assay were significantly higher in 
the gelatine sponge group than the HA/aragonite group at days 
7, 14 and 21.
The osteogenic capacity of the HA/aragonite was confirmed by 
$/3 DVVD\ 7KH $/3 DFWLYLW\ RI FHOOV VHHGHG RQ +$DUDJRQLWH
on gelatine sponge and of cells alone is shown in Figure 8. After 
GD\WKH$/3DFWLYLW\LQFUHDVHGVLJQLILFDQWO\RQJHODWLQHVSRQJH
HA/aragonite and in cells alone between day 1 and day 14 (3 < 
+RZHYHU$/3DFWLYLW\ LQ WKHJHODWLQH VSRQJHJURXSZDV
higher than that of cells on HA/aragonite at days 7 and 21.
In vitro degradation test of HA/aragonite
The degradation of the HA/aragonite was confirmed by 
degradation testing. The percentage degradation of the HA/
aragonite was determined by weight loss which can be defined 
by equation
(6)
The weight loss of HA/aragonite at day 3 was around 3.5%, 
increasing to 25.58% after day 14. The percentage weight loss of 
HA/aragonite increased significantly over time, while the weight 
loss of HA alone showed no significant difference with increasing 
time (Figure 9).
Juxtapositional implantation between tibia and tibialis 
anterior muscle in a rat model
The position of the HA/aragonite implanted between the tibia 
Figure 5. &RPSDUDWLRQRI WKH)RXULHUWUDQVIRUPLQIUDUHGVSHFWUDRI+$DUDJRQLWHDQGFDOFLXPFDUERQDWH7ULDQJOH
LQGLFDWHVWKDWWKHSHDNFRUUHVSRQGLQJWR324
3–; dot indicates that the peak corresponding to CO3
2–. 
Figure 6. 7KHUPRJUDYLPHWULFDQDO\VLVUHVXOWVRIK\GUR[\DSDWLWHDUDJRQLWH6WDJHJHODWLQHLQWKH+$DUDJRQLWHEHJLQV
to decompose; stage 2, aragonite begins to dramatically decompose; stage 3, residual components of CaO and HA are 
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and the tibialis anterior muscle in a rat is indicated in Figure 
10A. The HA/aragonite was firmly integrated into the tibia 
after 6 weeks. Figure 10B shows a microCT image of a gelatine 
sponge implanted in a rat model, in which only the tibia is visible, 
with no mineralisation of the gelatine. Figure 10C shows HA/
aragonite implanted in a rat model. The image shows that the 
HA/aragonite has the same density as bone, and HA/aragonite is 
firmly integrated with the indicated bone-like tissue.
As shown in Figure 11A, light microscopy revealed that at 6 
weeks after gelatine sponge implantation, fibrous tissue was 
formed between the tibia and the tibialis anterior muscle. The 
HA/aragonite samples implanted at the same time were covered 
mainly by connective tissue containing blood vessels, fibroblasts 
and some macrophages; in particular, there were patches of bone-
like tissue formation and minimal inflammatory response, as 
shown in Figure 11B7KH7(0UHVXOWV FRQILUPHG WKH ILQGLQJV
of light microscopy. In the gelatine sponge implantation group 
(Figure 11C) macrophagic responses were observed with 
fibroblast infiltration for tissue regeneration; whereas within the 
patch of bone-like tissue in the HA/aragonite group (Figure 11D), 
typical osteoblast-like cells with calcified lacunae and canaliculi–
like structure were observed, which confirmed that the marked 
area is likely to be new bone formation or callus formation.
Figure 7. (IIHFWRI+$DUDJRQLWHRQWKHYLDELOLW\RIKXPDQXPELOLFDOFRUGPDWUL[PHVHQFK\PDOVWHPFHOOVGHWHFWHGE\
GLPHWK\OWKLD]RO\OGLSKHQ\OWHWUD]ROLXPEURPLGH077DVVD\'DWDDUHH[SUHVVHGDVWKHPHDQr6(*3 < 
0.05 (two-way analysis of variance). HA: hydroxyapatite.
Figure 8. (IIHFWRI+$DUDJRQLWHRQWKH$/3DFWLYLW\RIKXPDQXPELOLFDOFRUGPDWUL[PHVHQFK\PDOVWHPFHOOV'DWDDUH
H[SUHVVHGDVWKHPHDQr6(*3WZRZD\DQDO\VLVRIYDULDQFH$/3DONDOLQHSKRVSKDWDVH+$K\GUR[\DSDWLWH
Figure 9. $%:HLJKWORVVSHUFHQWDJHRI+$DUDJRQLWH$DQG+$%'DWDDUHH[SUHVVHGDVWKHPHDQr6(*3< 0.05 
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Discussion
The results of this study demonstrated the ability to fabricate a 
composite HA/aragonite bone graft substitute that supports 
osteogenesis in vitro and in vivo.
In this study, the purpose of adding aragonite into HA was to 
enhance the biodegradation of the bone graft. It is well known 
that HA is a bone graft material which is slow to degrade and its 
degradation period can be more than 100 months44 which is far 
beyond the bone remodelling cycle of between 6 and 24 months. 
In order to increase biodegradation, a more biodegradable 
FHUDPLF ƺ7&3 LV DGGHG LQWR ERQH JUDIW PDWHULDOV44, 45 (YHQ
tKRXJK +$ƺ7&3 LV VLJQLILFDQWO\ PRUH GHJUDGDEOH WKDQ +$
DORQH WKHGHJUDGDWLRQSHULRGRI+$ƺ7&3LVDOVRUDWKHU ORQJ
reported to be more than 36 months.44, 45 It is therefore necessary 
to introduce more biodegradable bone graft materials, such 
as composites containing both HA and more soluble calcium 
carbonate, but apart from coralline HA, it is difficult to form 
HA composites containing calcium carbonate that also have the 
desired mechanical properties.
HA ceramics are normally sintered at between 1200–1300°C, 
whereas calcium carbonate undergoes thermal decomposition 
above 840°C:
Figure 10. Implantation of HA/aragonite in a rat model. (A) A specimen of the HA/aragonite (red circle) implanted 
between the tibia and the tibialis anterior muscle in a rat model. After 6 weeks the sample has become well integrated. 
(B) MicroCT of gelatine sponge implanted in a rat model. Only the tibia is visible, with no mineralised tissue formed in 
the sponge. (C) HA/aragonite implanted in a rat model. Interestingly, formation of bone-like tissue (arrow) can be seen 
EHWZHHQWKHWLELDDQGWKH+$DUDJRQLWH6FDOHEDUVPP+$K\GUR[\DSDWLWH
Figure 11. (A) Light microscopy (1 mm section stained with Toluidine blue) revealed that implantation of a gelatine 
sponge resulted in formation of fibrous tissue between the tibia and the tibialis anterior muscle. (B) At 6 weeks after HA/
aragonite implantation, the materials were covered by fibroblasts and macrophages; interestingly, there was a small patch 
of bone-like tissue formation. Transmission electron microscopy (100 nm section with uranyl acetate and lead citrate 
staining) observation confirmed the findings of light microscopy. In the control gelatine sponge implantation group (C), 
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CaCO3ҋ&D2&22                                                                         (7)
Therefore it is not possible to synthesise HA/aragonite through 
VLQWHULQJ,WKDVEHHQUHSRUWHGWKDWZKHQ77&3DQG'&3$DUH
mixed in double-distilled water, the dissolved ions precipitate on 
the surface of the material and can self-set into various forms of 
HA.31 By adding calcium carbonate into this mixture, it may be 
possible to produce bulk self-setting HA/aragonite without pores.
Additive manufacturing provides the ideal solution to producing 
a controllable porous structure. However, it is well known that 
the filter-pressing phenomenon leads to the separation of solid 
and liquid phases when the mixture of powders and aqueous 
solution are injected through a syringe.46, 47
The addition of gelatine solution formed a viscous and cohesive 
paste and created a strong combination between solid and liquid 
phases, thereby improving the injectability of the paste. The setting 
WLPHRI77&3'&3$LVѝPLQXWHVEXWWKHDGGLWLRQRIJHODWLQH
increases the setting time to around 30 minutes which makes the 
SDVWHV ѠSULQWDEOHѡ DQG DOORZV WKH IDEULFDWLRQ RI GHVLUHG IHDWXUHV
The precipitated particles were crystalline in texture which is 
similar to the observations reported in previous publications.48 
6WURQJ HYLGHQFH IRU WKH SUHVHQFH RI +$ ZDV SURYLGHG E\ WKH
peak which appeared at around 961 cm–1 7KH ǅ DEVRUSWLRQ
peak of CO3
2– was seen in the HA/aragonite, which indicated that 
calcium carbonate was present in the HA/aragonite after all the 
processing. The peaks had all shifted from the reference peaks but 
E\DUHDVRQDEOHYDOXH7KHDEVRUSWLRQSHDNRI+324
2– at 895 cm–1 
FDXVHGE\WKHGHFUHDVLQJ77&3'&3$UDWLRGLGQRWDSSHDULQWKH
HA/aragonite, indicating that there was no Ca9+324324)5(OH) 
present in the HA/aragonite.49
7KHFRPSUHVVLRQVWUHQJWKRIFDQFHOORXVERQHLVѝ03DDQG
the porosity is 50–90%.50 The compression strength of the HA/
DUDJRQLWHZHIDEULFDWHGZDV03DDQGWKHKLJKHVWSRURVLW\RI
HA/aragonite is 42.8%, indicating that the strength and porosity 
of HA/aragonite are comparable to those of cancellous bone. The 
SRUHVL]HRI+$DUDJRQLWHZDVDURXQGǄPZKLFKLVVXLWDEOH
for tissue ingrowth.51 As the porosity of the HA/aragonite 
increases, its compression strength decreases. Recent studies have 
reported the same issue,52 and consequently further research is 
needed to improve the mechanical strength. 
In this study, significant weight loss was noted between successive 
time points, indicating that HA/aragonite is a degradable 
material, which confirmed the previous finding of the in vitro 
biodegradation of calcium carbonate.53
As a potential bone graft substitute, it is important that this 
new material is able to enhance osteogenesis and promote bone 
formation. It is well documented that HA and calcium carbonate, 
used either alone or combined, have demonstrated osteogenicity 
and bone conductivity.1, 4, 7, 8, 15 In the present study, HA/aragonite 
VXSSRUWHG$/3DFWLYLW\RIPHVHQFK\PDOVWHPFHOOVin vitro, which 
is a sign of enhanced osteogenicity. 
HA/aragonite was compared with clinically-used gelatine sponges 
which consist of gelatine alone. Interestingly, gelatine sponges 
VKRZHGJUHDWHUFHOOQXPEHUVDQG$/3DFWLYLWLHVin vitro compared 
with HA/aragonite. This may be due to the fact that gelatine 
sponges are much more porous than HA/aragonite, thus allowing 
more cell penetration and growth over the 3-week period of cell 
culture. However, after implantation, no bone formation was 
observed in the gelatine sponge group in vivo.
Conductive bone formation can only be observed in vivo. In order 
to observe the tissue response to HA/aragonite, this bone graft 
material was implanted between the tibialis anterior muscle and 
the tibia. No bone defects were created, as the initial plan was to 
exclude any potential adverse effect of this material. Unexpectedly, 
at the time the implants were harvested, the HA/aragonite was 
firmly integrated into the tibia. New bone formation between the 
HA/aragonite and the tibia was confirmed by microCT, with bony 
material bridging the implant to the tibia bone. The presence of 
bone-like tissue on the surface of the implants was also confirmed 
by both light and transmission electron microscopy. 
Undifferentiated cells from muscles and blood vessel walls have 
osteogenic potential.54 The formation of bone on the surface 
of calcium phosphate scaffolds in intramuscular sites has been 
reported by several studies.55-57 The precipitation and dissolution of 
WKHPDWHULDOѡVVXUIDFHSOD\VDQLPSRUWDQWUROHLQWKHLQWUDPXVFXODU
osteogenesis process.57, 58 In this study, the HA/aragonite formed 
a biodegradable bone graft. When HA/aragonite is implanted in 
the body, the process of interaction between the implant and the 
surrounding body fluid or tissue can be activated. The dissolution 
of aragonite should increase the concentration of Ca2+ on the 
surface of the material resulting in the formation of apatite-like 
phosphate by absorbing proteins and growth factors.57 The fast 
degradation rate of aragonite may be responsible for the early 
signs of osteogenesis, while other animal studies only showed 
signs of osteogenesis after 45 days.56, 59 In the current study, we 
not only observed small patches of bone-like tissue formation 
on the HA/aragonite when implanted in muscle, but also a large 
amount of visible bone formation between the HA/aragonite and 
the tibia. 
Our results show that the HA/aragonite did not induce any 
adverse tissue responses after implantation between the tibia and 
the tibialis anterior muscle, but demonstrated conductive bone 
IRUPDWLRQ EHWZHHQ WKH LPSODQW DQG WKH WLELD )XUWKHU VWXG\ LV
needed to understand the mechanism involved. 
Within this study, there are a number of limitations. The first 
purpose of this study was to achieve the biofabrication of a 
QRYHO+$DUDJRQLWH ERQHJUDIW VXEVWLWXWHXVLQJ'ELRSULQWLQJ
WHFKQLTXHV (YHQ WKRXJK WKH PDWHULDO IDEULFDWLRQ SURFHVV ZDV
successful, the ratio of raw materials in the formulation may not 
be optimal in terms of the mechanical strength, biodegradation 
DQGRVWHRJHQLFLW\RIWKHSURGXFW6HFRQGO\WKHSDUDPHWHUVXVHG
DUHGHVLJQHGIRUXVHLQD'%LRSORWWHU® and may not be directly 
transferrable to other types of additive manufacturing devices. 
Thirdly, the favourable results of HA/aragonite in vitro and in 
vivo are still preliminary. More comprehensive and systematic 
studies are needed to explore the full potential of HA/aragonite 
on osteogenesis and biodegradation. 
,Q VXPPDU\ WKH 'ELRSULQWHG ERQH JUDIW VXEVWLWXWH +$
aragonite prepared in this study is a porous, biodegradable 
and nontoxic HA/calcium carbonate composite material with 
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osteogenic capability. By controlling the printing parameters, 
SURGXFWVL]HDQGSRURVLW\ZHUHIDEULFDWHGZLWKLQWKHUDQJHGHVLUHG
for bone grafts. HA/aragonite can be printed with high resolution 
to achieve versatile geometries that are critical for fluid exchange 
and cellular ingrowth during bone healing. The mechanical 
strength and porosity of the HA/aragonite are comparable to 
those of cancellous bone, which allows implantation into a 
non-loading bone defect. In vitro and in vivo experiments were 
performed successfully showing suitability for bone formation. 
6LQFHWKLVPDWHULDOLVIRUPHGDURXQGq&WKHUHLVJUHDWSRWHQWLDO
for the incorporation of bioactive particles to suit personalised 
DSSOLFDWLRQ)XWXUHVWXGLHVZLOOIRFXVRQIXUWKHURSWLPLVDWLRQRIWKH
formulae to strengthen the mechanical properties with extensive 
evaluation of the effects on osteogenicity and biodegradation.
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